Atlas Trials

To Evaluate the Efficacy and Safety of NMN as an Anti-ageing Supplement in Middle Aged and Older (40-65 Years) Adults

Clinical trial NCT04823260 · COMPLETED

Trial details

NCT number
NCT04823260
Sponsor
Abinopharm, Inc
Status
COMPLETED
Phase
Not Applicable
Study type
INTERVENTIONAL
Aging
Start date
2021-05-25
Primary completion
2021-09-09
Enrollment
90

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.